Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABVX Abivax S.A.

Market Closed 06-05 16:00:00 EDT

101.53

-3.40

-3.24%

盘后101.23

-0.30-0.30%

19:58 EDT

High108.18	Low98.23	Vol2.63M
Open105.18	D1 Closing104.93	Amplitude9.48%
Mkt Cap8.04B	Tradable Cap4.33B	Total Shares79.19M
T/O268.06M	T/O Rate6.15%	Tradable Shares42.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABVX","market":"US","secType":"STK","nameCN":"Abivax S.A.","latestPrice":101.53,"timestamp":1780689600000,"preClose":104.93,"halted":0,"volume":2625300,"hourTrading":{"tag":"盘后","latestPrice":101.23,"preClose":101.53,"latestTime":"19:58 EDT","volume":7833,"amount":791946.66,"timestamp":1780703926360,"change":-0.3,"changeRate":-0.002955,"amplitude":0.026349},"delay":0,"changeRate":-0.03240255408367488,"floatShares":42655700,"shares":79185160,"eps":-5.216782,"marketStatus":"Market Closed","change":-3.4,"latestTime":"06-05 16:00:00 EDT","open":105.18,"high":108.175,"low":98.23,"amount":268062268.437,"amplitude":0.094777,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.216782,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1697774400000,"exchange":"NASDAQ","adjPreClose":104.93,"preHourTrading":{"tag":"盘前","latestPrice":105.48,"preClose":104.93,"latestTime":"09:29 EDT","volume":88118,"amount":9308603.11574,"timestamp":1780666199999,"change":0.55,"changeRate":0.005242,"amplitude":0.041833},"postHourTrading":{"tag":"盘后","latestPrice":101.23,"preClose":101.53,"latestTime":"19:58 EDT","volume":7833,"amount":791946.66,"timestamp":1780703926360,"change":-0.3,"changeRate":-0.002955,"amplitude":0.026349},"volumeRatio":0.3407026620566737,"impliedVol":1.2539,"impliedVolPercentile":0.8603},"requestUrl":"/m/hq/s/ABVX/wiki","defaultTab":"wiki","newsList":[{"id":"1169511769","title":"Movement Alert｜Abivax S.A. Falls 5.49% in Regular Trading, Phase 3 Trial Cancer Case Safety Concerns Continue to Weigh on Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1169511769","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169511769?lang=en_us&edition=fundamental","pubTime":"2026-06-05 23:19","pubTimestamp":1780672794,"startTime":"0","endTime":"0","summary":"On June 5, Abivax S.A. declined 5.49% in regular trading, trading at $99.52/share, with trading volume of $128 million. The decline reflects persistent safety concerns surrounding the company's core...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101208168","title":"Movement Alert｜Abivax S.A. Rises 5.65% in Regular Trading, Extending Rebound After Phase 3 Trial Cancer Scare Triggered 40%+ Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1101208168","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101208168?lang=en_us&edition=fundamental","pubTime":"2026-06-04 22:13","pubTimestamp":1780582405,"startTime":"0","endTime":"0","summary":"On June 4, Abivax S.A. rose 5.65% in regular trading, trading at $98.5/share, with trading volume of $127 million. The stock continues to rebound after plunging over 40% earlier this week.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640718935","title":"This Is Why Abivax Stock (ABVX) Is Up Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2640718935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640718935?lang=en_us&edition=fundamental","pubTime":"2026-06-04 02:41","pubTimestamp":1780512084,"startTime":"0","endTime":"0","summary":"Abivax stock was up after one of the company’s clinical trials was a success.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/this-is-why-abivax-stock-abvx-is-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/this-is-why-abivax-stock-abvx-is-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640850381","title":"Abivax price target lowered to $136 from $176 at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2640850381","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640850381?lang=en_us&edition=fundamental","pubTime":"2026-06-04 01:20","pubTimestamp":1780507227,"startTime":"0","endTime":"0","summary":"Wolfe Research lowered the firm’s price target on Abivax (ABVX) to $136 from $176 and keeps an Outperform rating on the shares. The firm believes t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-price-target-lowered-to-136-from-176-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-price-target-lowered-to-136-from-176-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640183455","title":"Abivax rises 14.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640183455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640183455?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:55","pubTimestamp":1780502123,"startTime":"0","endTime":"0","summary":"Abivax (ABVX) is up 14.1%, or $10.24 to $82.74. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-rises-14-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-rises-14-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131577819","title":"Movement Alert｜Abivax S.A. Rises 16.03% in Regular Trading, Partial Rebound After Phase 3 Trial Cancer Cases Triggered 40% Plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=1131577819","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131577819?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:38","pubTimestamp":1780493880,"startTime":"0","endTime":"0","summary":"On June 3, Abivax S.A. rose 16.03% in regular trading, trading at approximately $83.95/share, with trading volume of $145 million. The stock is experiencing a sharp intraday rebound following a more...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119636189","title":"Movement Alert｜Abivax S.A. Rises 6.21% in Pre-Market Trading, Partial Rebound After Phase 3 Trial Cancer Concerns Triggered 40% Crash","url":"https://stock-news.laohu8.com/highlight/detail?id=1119636189","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119636189?lang=en_us&edition=fundamental","pubTime":"2026-06-03 16:59","pubTimestamp":1780477188,"startTime":"0","endTime":"0","summary":"On June 3, Abivax S.A. rose 6.21% in pre-market trading, trading at $77.0/share, with trading volume of $4.18 million. The stock is experiencing a partial rebound following a dramatic selloff in the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640972146","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Bausch Health Companies (BHC) and Healthequity (HQY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972146","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640972146?lang=en_us&edition=fundamental","pubTime":"2026-06-03 16:10","pubTimestamp":1780474210,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Abivax SA Sponsored ADR (ABVX), Bausch Health Comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-abivax-sa-sponsored-adr-abvx-bausch-health-companies-bhc-and-healthequity-hqy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-abivax-sa-sponsored-adr-abvx-bausch-health-companies-bhc-and-healthequity-hqy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU1169589451.USD","HQY","BHC","BK4581","BK4007","ABVX","BK4588","LU0029874061.USD","LU0128526141.USD","HCSG","LU2210150020.SGD","BK4585","XLV","BK4137","LU2095319765.USD","LU2065731478.USD","BK4154","LU2210149790.SGD","LABU","LU1169590202.USD","XBI","AAVXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142631811","title":"Movement Alert｜Abivax S.A. Rises 5.28% Overnight, Partial Rebound After 40% Crash on Phase 3 Trial Cancer Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1142631811","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142631811?lang=en_us&edition=fundamental","pubTime":"2026-06-03 11:08","pubTimestamp":1780456086,"startTime":"0","endTime":"0","summary":"On June 2, Abivax S.A. rose 5.28% overnight, trading at 76.37 USD/share, with trading volume of $366,100. The stock saw a modest rebound following a dramatic intraday plunge of over 40% earlier in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142007563","title":"Movement Alert｜Abivax S.A. Rises 5.12% in After-Hours Trading, Modest Rebound Following 40% Intraday Plunge on Phase 3 Cancer Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1142007563","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142007563?lang=en_us&edition=fundamental","pubTime":"2026-06-03 05:18","pubTimestamp":1780435095,"startTime":"0","endTime":"0","summary":"On June 2, Abivax S.A. rose 5.12% in after-hours trading to approximately $76.50 per share, with trading volume of $4.08 million. The move represents a modest technical rebound following a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640294013","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2640294013","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640294013?lang=en_us&edition=fundamental","pubTime":"2026-06-03 02:25","pubTimestamp":1780424751,"startTime":"0","endTime":"0","summary":"Abivax  faces an increasing risk of a black box warning for obefazimod due to malignancies reported from a recent trial, Wedbush Securities said in a note.Shares sank 42% following an increase in intraday trading volume to over 14 million from a daily average of about 1.1 million.Fulcrum Therapeutics  shares slumped 52% amid heavy trading after multiple analysts downgraded the stock and sharply lowered their price targets.Intraday trading volume soared to more than 23.3 million shares from a daily average of about 910,000.Goldman Sachs downgraded Intuit  to sell from neutral while adjusting its price target to $276 from $519.Shares dropped over 8%, with intraday trading volume rising to more than 5.1 million versus the stock's daily average of about 4.12 million.Price: 74.19, Change: -55.50, Percent Change: -42.79","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0957791311.USD","LU2023251221.USD","LU2065170008.USD","IE00BQXX3F31.USD","LU1037948897.HKD","IE00B5949003.HKD","LU0289739343.SGD","LU1235294995.USD","INTU","LU1804176565.USD","BK4533","LU1236620750.USD","LU2063271972.USD","LU0266013472.USD","LU0861579265.USD","LU2089283258.USD","LU0345774631.USD","LU0823434740.USD","BK4528","LU0289961442.SGD","LU1823568750.SGD","LU0345774391.USD","LU0823434583.USD","LU2065169927.USD","LU2095319765.USD","IE00BQXX3C00.GBP","SG9999001424.SGD","LU0011850046.USD","ABVX","BK4534","LU0426412945.USD","LU0157215616.USD","LU0109392836.USD","LU0661504455.SGD","LU1280957306.USD","LU2265009873.SGD","LU1674673428.USD","BK4023","LU1043141123.HKD","LU0082616367.USD","FULC","LU0965509010.AUD","LU0426417589.USD","BK4588","LU0158827948.USD","LU1366333091.USD","LU1043141396.HKD","LU1037948541.HKD","BK4567","LU0124676726.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640947738","title":"Sector Update: Healthcare Stocks Fall in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2640947738","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640947738?lang=en_us&edition=fundamental","pubTime":"2026-06-03 01:54","pubTimestamp":1780422842,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each falling 1.1%.The iShares Biotechnology ETF  dropped 3%.In corporate news, Abivax  faces an increasing risk of black box warning for obefazimod due to malignancies reported from a recent trial, Wedbush Securities said in a note. Abivax shares fell nearly 42%.Heron Therapeutics  shares dropped 39% after the company said the US District Court for the District of Delaware has ruled that claims in two of its Cinvanti injectable emulsion patents are invalid.Praxis Precision Medicines'  shares tumbled 16% after it reported late Monday that its phase 2/3 trial assessing vormatrigine to treat focal onset seizures failed to meet its primary endpoint of percent change in monthly seizure frequency from baseline.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LU0889565916.HKD","ABVX","HRTX","BK4588","IBB","IE00BFTCPJ56.SGD","PRAX","BK4137","LU0109394709.USD","IE0009355771.USD","LABU","BK4585","XLV","IE00B4R5TH58.HKD","IE0002141913.USD","HCSG","IE00B2B36J28.USD","LU0029874061.USD","IE00BJT1NW94.SGD","BK4581","LU0320765992.SGD","XBI","IE00BJJMRZ35.SGD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640579942","title":"Abivax falls -40.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640579942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640579942?lang=en_us&edition=fundamental","pubTime":"2026-06-03 00:09","pubTimestamp":1780416570,"startTime":"0","endTime":"0","summary":"Abivax (ABVX) is down -40.3%, or -$52.26 to $77.43. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-falls-40-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-falls-40-3-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640494105","title":"Abivax Faces Increasing Risk of Black Box Warning for Obefazimod, Wedbush Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2640494105","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640494105?lang=en_us&edition=fundamental","pubTime":"2026-06-02 23:17","pubTimestamp":1780413459,"startTime":"0","endTime":"0","summary":"Abivax  faces an increasing risk of black box warning for obefazimod due to malignancies reported from a recent trial, Wedbush Securities said in a Tuesday note.The company said Monday that the phase 3 maintenance trial evaluating obefazimod in adults with moderately to severely active ulcerative colitis met its primary endpoint, with both 25 mg and 50 mg doses also achieving all key secondary endpoints.Wedbush noted the seven malignancies reported in the trial's 50 mg cohort and one in the 25 mg, along with the novel proposed mechanism for obefazimod, as signals for an eventual black box warning. The brokerage also flagged this warning's potential negative impact on market share and marketing costs.The possible regulatory and commercial delays could also pressure profitability based on obefazimod's patent life, Wedbush added, while noting obefazimod's potent monotherapy efficacy with a top-line clinical remission rate of 50% for both doses.Wedbush Securities upgraded Abivax to neutral","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","BK4139","LU0012050646.USD","LU0240877869.USD","LU0240878834.USD","BOX","ABVX","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640946211","title":"Abivax price target lowered to $135 from $140 at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2640946211","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640946211?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:47","pubTimestamp":1780408042,"startTime":"0","endTime":"0","summary":"Truist lowered the firm’s price target on Abivax (ABVX) to $135 from $140 and keeps a Buy rating on the shares. The company reported topline mainte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abivax-price-target-lowered-to-135-from-140-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abivax-price-target-lowered-to-135-from-140-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187918534","title":"Movement Alert｜Abivax S.A. Falls 40.7% in Regular Trading, Phase 3 Trial Data Complicated by Cancer Cases Triggers Market Panic","url":"https://stock-news.laohu8.com/highlight/detail?id=1187918534","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187918534?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:38","pubTimestamp":1780407509,"startTime":"0","endTime":"0","summary":"On June 2, Abivax S.A. fell 40.7% in regular trading, trading at $82.725/share, with trading volume of $320 million. The sharp decline was triggered by the company's disclosure of Phase 3 maintenance...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943379","title":"Leerink Partners Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640943379?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:37","pubTimestamp":1780403839,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst reiterated a Buy rating on Abivax SA Sponsored ADR today and set a price target of $140.00. In addition to Leerink Partner...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/leerink-partners-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/leerink-partners-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAVXF","ABVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640105469","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640105469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640105469?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:40","pubTimestamp":1780400415,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abivax SA Sponsored ADR (ABVX), Agilent (A) and Scho...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-200?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-200?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","A","LU2413666426.HKD","IE00BN0W2T93.GBP","BK4139","LU0347712357.USD","BK4585","LU1165135440.EUR","BK4567","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","ABVX","LU2092937221.SGD","LU2041044095.USD","LU1721428933.USD","LU2229751404.USD","BK4588","LU2089279066.USD","LU1543694498.USD","LU2413666699.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640891087","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2640891087","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640891087?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:36","pubTimestamp":1780400180,"startTime":"0","endTime":"0","summary":"Fulcrum Therapeutics  shares were down 49% in Tuesday premarket activity after multiple analysts downgraded the stock and sharply lowered their price targets.Jianzhi Education Technology  stock was down 43%, after a 325% gain in Monday's session.Abivax  stock was down 30% after the company's phase 3 maintenance trial evaluating obefazimod in ulcerative colitis met its primary endpoint and key secondary endpoints, though malignancy cases reported during the trial weighed on the results.Hitek Global  shares were down 21%, following the previous session's 350% gain.Quhuo  shares were down 20%, extending losses from the previous session.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FULC","BK4007","BK4204","HKIT","QH","BK4137","BK4134","ABVX","BK4139","JZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640173299","title":"Abivax Sa : Truist Securities Cuts Target Price to $135 From $140","url":"https://stock-news.laohu8.com/highlight/detail?id=2640173299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640173299?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:09","pubTimestamp":1780398562,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nFWN42A0FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABVX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abivax.com","stockEarnings":[{"period":"1week","weight":-0.2345},{"period":"1month","weight":-0.1976},{"period":"3month","weight":-0.0713},{"period":"6month","weight":-0.1134},{"period":"1year","weight":11.4577},{"period":"ytd","weight":-0.2471}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.","exchange":"NASDAQ","name":"Abivax S.A.","nameEN":"Abivax S.A.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Abivax S.A.(ABVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Abivax S.A.,ABVX,Abivax S.A.股票,Abivax S.A.股票老虎,Abivax S.A.股票老虎国际,Abivax S.A.行情,Abivax S.A.股票行情,Abivax S.A.股价,Abivax S.A.股市,Abivax S.A.股票价格,Abivax S.A.股票交易,Abivax S.A.股票购买,Abivax S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Abivax S.A.(ABVX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Abivax S.A.(ABVX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}